FMR LLC has filed an updated Schedule 13G/A with the SEC, revealing that it now holds approximately 7.8% of Camp4 Therapeutics Corp's common stock. This significant stake underscores FMR's confidence in the pharmaceutical preparations company and its future prospects.
Camp4 Therapeutics Corp, a company focused on pharmaceutical preparations, operates under the ticker CAMP on the Nasdaq exchange. The company is classified under the SIC code 2834, which pertains to pharmaceutical preparations. This recent filing, dated November 5, 2026, is part of a series of disclosures made by FMR LLC, indicating a growing interest in Camp4's operations and potential.
According to the filing, FMR LLC beneficially owns 4,908,857 shares of Camp4, with sole voting and dispositive power over these shares. Abigail P. Johnson, a key figure at FMR LLC, is also noted in the filing, highlighting her role as a significant stakeholder.
This updated ownership stake may influence various stakeholders, including investors and market analysts, as it reflects FMR LLC's strategic positioning within the pharmaceutical sector. The filing also indicates that members of the Johnson family, through their ownership of Series B voting common shares, may form a controlling group with respect to FMR LLC.
The filing does not specify what actions FMR LLC may take next regarding its stake in Camp4 Therapeutics. However, it does suggest a continued interest in the company's developments and future growth.
Read Next
Manthripragada Vijay Acquires Additional Shares in Onterris
Laws James Acquires Shares in Onterris, Inc. via RSUs
Eightco Holdings CEO Acquires 100,000 Shares of Stock
Eightco CFO Vroman Acquires 15,000 Shares in Stock Transaction
Orchestra BioMed CFO Acquires Shares in Recent Filing
Upwork CFO Erica Gessert Reports Major Stock Transactions




